Data / Drug companies / Lorazepam
Lorazepam: 38 companies and 146 products in the FDA NDC directory
Lorazepam is listed in the FDA National Drug Code Directory by 38 companies, with 146 products in commercial distribution. 124 of the products (84.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection; capsule, extended release, and the newest product started marketing on September 24, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 38
- Products
- 146
- Generic (ANDA) products
- 124 (84.9%)
- Application numbers
- 19
- Controlled substance schedule
- Schedule IV
- Routes
- Oral, Intramuscular, Intravenous
- Brand names
- Ativan, Loreev XR
- openFDA record search
- api.fda.gov
Companies that list lorazepam
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | 14 | tablet | Generic drugs (ANDA) | December 19, 2023 |
| Hikma Pharmaceuticals USA Inc. | 13 | injection | New drug applications (NDA) | July 25, 1980 |
| Remedyrepack Inc. | 12 | tablet; injection, solution | Generic drugs (ANDA) | February 5, 2025 |
| NuCare Pharmaceuticals,Inc. | 11 | tablet | Generic drugs (ANDA) | June 25, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet | Generic drugs (ANDA) | October 26, 2023 |
| Bryant Ranch Prepack | 6 | tablet | Generic drugs (ANDA) | May 16, 2023 |
| A-S Medication Solutions | 5 | tablet; capsule, extended release | Generic drugs (ANDA) | May 16, 2023 |
| Clinical Solutions Wholesale, LLC | 5 | tablet | Generic drugs (ANDA) | June 25, 2023 |
| Almatica Pharma LLC | 4 | capsule, extended release | New drug applications (NDA) | March 1, 2022 |
| Asclemed USA, Inc. | 4 | tablet | Generic drugs (ANDA) | June 25, 2023 |
| Chartwell RX, LLC | 4 | tablet; concentrate | Generic drugs (ANDA) | April 28, 2009 |
| Preferred Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | July 31, 2026 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | October 11, 2021 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | September 14, 2025 |
| Ani Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | December 1, 2024 |
| Aurolife Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | February 1, 2021 |
| Bausch Health US LLC | 3 | tablet | New drug applications (NDA) | May 1, 2013 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | June 22, 2026 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | October 31, 1991 |
| Leading Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | May 16, 2023 |
| Redpharm Drug | 3 | tablet | Generic drugs (ANDA) | December 9, 2021 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | July 24, 2025 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet | Generic drugs (ANDA) | June 25, 2023 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | December 9, 2021 |
| Unit Dose Solutions, Inc. | 3 | tablet | Generic drugs (ANDA) | September 24, 2026 |
| American Health Packaging | 2 | liquid | Generic drugs (ANDA) | May 1, 2026 |
| Fresenius Kabi USA, LLC | 2 | injection | Generic drugs (ANDA) | December 13, 2024 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Generic drugs (ANDA) | July 7, 2026 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | December 28, 2024 |
| Amneal Pharmaceuticals LLC | 1 | concentrate | Generic drugs (ANDA) | February 1, 2010 |
| Civica, Inc. | 1 | injection | New drug applications (NDA) | December 7, 2020 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | February 10, 2017 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | April 29, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | June 28, 1991 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 6, 2005 |
| International Medication Systems, Limited | 1 | injection | Generic drugs (ANDA) | December 1, 2012 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | liquid | Generic drugs (ANDA) | November 1, 2010 |
| PharmPak, Inc. | 1 | tablet | Generic drugs (ANDA) | July 11, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 116 | 79.5% |
| Injection | 17 | 11.6% |
| Capsule, extended release | 5 | 3.4% |
| Liquid | 3 | 2.1% |
| Concentrate | 2 | 1.4% |
| Injection, solution | 2 | 1.4% |
| Solution, concentrate | 1 | 0.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 124 | 84.9% |
| New drug applications (NDA) | 22 | 15.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Benzodiazepine | 146 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.